Inactivation of the cerebral NFκB pathway inhibits interleukin-1β-induced sickness behavior and c-Fos expression in various brain nuclei

Neuropsychopharmacology

Volumn 30, Issue 8, 2005, Pages 1492-1499

  Nadjar, Agnès ^a   Bluthé, Rose Marie ^a   May, Michael J ^b   Dantzer, Robert ^a   Parnet, Patricia ^a,c  

^a CNRS   (France)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

c Fos; In vivo; Interleukin 1 ; NFkappaB; Sickness behavior

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEMO BINDING DOMAIN PEPTIDE; PROTEIN C FOS; RECOMBINANT INTERLEUKIN 1BETA; UNCLASSIFIED DRUG; ENZYME INHIBITOR; INTERLEUKIN 1;

ADOLESCENT; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BODY WEIGHT; BRAIN BLOOD VESSEL; BRAIN NUCLEUS; BRAIN REGION; CELL ACTIVATION; CONTROLLED STUDY; ENZYME SYNTHESIS; FOOD INTAKE; ILLNESS BEHAVIOR; IMMOBILIZATION; IMMUNOSTIMULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSOCIAL WITHDRAWAL; RAT; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; BRAIN; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; EATING; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HISTOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; TIME; TONIC IMMOBILITY; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; DRUG INTERACTIONS; EATING; ENZYME INDUCTION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMOBILITY RESPONSE, TONIC; INTERLEUKIN-1; MALE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; TIME FACTORS;

EID: 23844447351     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300755     Document Type: Article

References (46)

1. Anforth HR, Bluthe RM, Bristow A, Hopkins S, Lenczowski MJ, Luheshi G et al (1998). Biological activity and brain actions of recombinant rat interleukin-1 alpha and interleukin-1beta. Eur Cytokine Netw 9: 279-288.
2. Baeuerle PA, Henkel T (1994). Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-179.
3. Bluthe RM, Castanon N, Pousset F, Bristow A, Ball C, Lestage J et al (1999). Central injection of IL-1 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 24: 301-311.
4. Bluthe RM, Crestani F, Kelley KW, Dantzer R (1992a). Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF. Ann N Y Acad Sci 650: 268-275.
5. Bluthe RM, Dantzer R, Kelley KW (1992b). Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res 573: 318-320.
6. Bluthe RM, Michaud B, Kelley KW, Dantzer R (1996a). Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport 7: 1485-1488.
7. Bluthe RM, Michaud B, Kelley KW, Dantzer R (1996b). Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport 7: 2823-2827.
8. Bluthe RM, Michaud B, Kelley KW, Dantzer R (1997). Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice. Physiol Behav 62: 385-389.
9. Bluthe RM, Sparber S, Dantzer R (1992c). Modulation of the behavioural effects of interleukin-1 in mice by nitric oxide. Neuroreport 3: 207-209.
10. Bluthe RM, Walter V, Parnet P, Laye S, Lestage J, Verrier D et al (1994). Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III 317: 499-503.
11. Brady LS, Lynn AB, Herkenham M, Gottesfeld Z (1994). Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J Neurosci 14: 4951-4964.
12. Dantzer R (2001). Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933: 222-234.
13. Dantzer R (2004). Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500: 399-411.
14. Dantzer R, Wollman EE, Vitkovic L, Yirmiya R (1999). Cytokines, stress, and depression. Conclusions and perspectives. Adv Exp Med Biol 461: 317-329.
15. Dasgupta S, Jana M, Zhou Y, Fung YK, Ghosh S, Pahan K (2004). Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis. J Immunol 173: 1344-1354.
16. Day HE, Akil H (1996). Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology 63: 207-218.
17. Dinarello CA (2000). The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343: 732-734.
18. Ericsson A, Kovacs KJ, Sawchenko PE (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14: 897-913.
19. Ericsson A, Liu C, Hart RP, Sawchenko PE (1995). Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361: 681-698.
20. Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454.
21. Hayden MS, Ghosh S (2004). Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
22. Herkenham M, Lee HY, Baker RA (1998). Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J Comp Neurol 400: 175-196.
23. Kent S, Bluthe RM, Dantzer R, Hardwick AJ, Kelley KW, Rothwell NJ et al (1992). Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci USA 89: 9117-9120.
24. Konsman JP, Cartmell T (1997). Neural pathways from the immune system to the brain. International Workshop organized under the auspices of the BIO-MED I Concerted Action 'Cytokines in the brain.' Marseille, 7 December 1996. Eur Cytokine Netw 8: 221-223.
25. Konsman JP, Dantzer R (2001). How the immune and nervous systems interact during disease-associated anorexia. Nutrition 17: 664-668.
26. Konsman JP, Luheshi GN, Bluthe RM, Dantzer R (2000a). The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci 12: 4434-4446.
27. Konsman JP, Tridon V, Dantzer R (2000b). Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience 101: 957-967.
28. Konsman JP, Vigues S, Mackerlova L, Bristow A, Blomqvist A (2004). Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 472: 113-129.
29. Krueger JM, Obal Jr F, Fang J (1999). Humoral regulation of physiological sleep: cytokines and GHRH. J Sleep Res 8(Suppl 1): 53-59.
30. Laflamme N, Rivest S (1999). Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J Neurochem 73: 309-321.
31. Laflamme N, Lacroix S, Rivest S (1999). An essential role of interleukin-1 beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 19: 10923-10930.
32. Marvel FA, Chen CC, Badr N, Gaykema RP, Goehler LE (2004). Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav Immunol 18: 123-134.
33. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S (2000). Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289: 1550-1554.
34. Mercier F, Kitasako JT, Hatton GI (2003). Fractones and other basal laminae in the hypothalamus. J Comp Neurol 455: 324-340.
35. Miyamoto S, Verma IM (1995). Rel/NF-kappa B/I kappa B story. Adv Cancer Res 66: 255-292.
36. Moynagh PN, Williams DC, O'Neill LA (1994). Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. J Immunol 153: 2681-2690.
37. Mulla A, Buckingham JC (1999). Regulation of the hypothalamo-pituitary- adrenal axis by cytokines. Baillieres Best Pract Res Clin Endocrinol Metab 13: 503-521.
38. Nadjar A, Combe C, Laye S, Tridon V, Dantzer R, Amedee T et al (2003). Nuclear factor kappaB nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse. J Neurochem 87: 1024-1036.
39. Nadjar A, Tridon V, May MJ, Ghosh S, Dantzer R, Amédée T et al (2005). NFkappaB activates in vivo the synthesis of inducible Cox-2 in the brain. J Cereb Blood Flow Metab 9 March [Epub ahead of print].
40. O'Neill LA, Greene C (1998). Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63: 650-657.
41. Propes MJ, Johnson RW (1997). Role of corticosterone in the behavioral effects of central interleukin-1 beta. Physiol Behav 61: 7-13.
42. Sagar SM, Price KJ, Kasting NW, Sharp FR (1995). Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res Bull 36: 381-392.
43. Shapiro RE, Miselis RR (1985). The central neural connections of the area postrema of the rat. J Comp Neurol 15: 344-364.
44. Shu SY, Ju G, Fan LZ (1988). The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85: 169-171.
45. Swanson LW (1998). Brain Maps: Structure of the Rat Brain 2nd edn, Elsevier: Amsterdam.
46. Turrin NP, Plata-Salaman CR (2000). Cytokine-cytokine interactions and the brain. Brain Res Bull 51: 3-9.